During the past decade, Neurocenter of Southern Switzerland conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Neurocenter of Southern Switzerland" #1 sponsor was "Bioprojet" with 2 trials, followed by "Mauro Manconi" with 1 trials sponsored, "Neurocenter of Southern Switzerland" with 1 trials sponsored, "Ospedale Regionale di Lugano" with 1 trials sponsored and "Stephany Fulda" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neurocenter of Southern Switzerland" #1 collaborator was "Cardiocentro Ticino" with 1 trials as a collaborator, "University Hospital Inselspital, Berne" with 1 trials as a collaborator, "University of Bologna" with 1 trials as a collaborator, "University of Milan" with 1 trials as a collaborator and "University of Turin, Italy" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Neurocenter of Southern Switzerland" are "Cataplexy" (2 trials), "Excessive Daytime Sleepiness" (2 trials), "Narcolepsy" (2 trials), "Restless Legs Syndrome" (2 trials) and "Depression" (1 trials). Many other conditions were trialed in "Neurocenter of Southern Switzerland" in a lesser frequency.

Most popular intervention types in "Neurocenter of Southern Switzerland" are "Drug" (3 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "BF2.649" (2 trials), "Placebo" (2 trials), "Acute sleep deprivation" (1 trials), "BF2.649 add on Modafinil" (1 trials) and "Modafinil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neurocenter of Southern Switzerland" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Neurocenter of Southern Switzerland". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Neurocenter of Southern Switzerland, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Neurocenter of Southern Switzerland, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".